Top

Published in:

01-04-2008 | Original Article

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study

Authors: A. Papaioannou, C. C. Kennedy, G. Ioannidis, Y. Gao, A. M. Sawka, D. Goltzman, A. Tenenhouse, L. Pickard, W. P. Olszynski, K. S. Davison, S. Kaiser, R. G. Josse, N. Kreiger, D. A. Hanley, J. C. Prior, J. P. Brown, T. Anastassiades, J. D. Adachi, CaMos Research Group

Published in: Osteoporosis International | Issue 4/2008

Abstract

Summary

We examined osteoporosis diagnosis/treatment in 2,187 community dwelling men age 50+. After five years in the study, 90% of men with fragility fractures remained undiagnosed and untreated for osteoporosis. The need to treat fragility fractures is well established in guidelines, and these numbers represent an important care gap.

Introduction

Whether physicians in the community are recognizing and appropriately treating osteoporosis and fragility fractures in men remains unknown. We examined the rate of diagnosis and treatment in community dwelling men participating in the Canadian Multicentre Osteoporosis Study (CaMos).

Methods

Between February 1996 and September 2002, 2,187 participants were recruited from nine sites across Canada and prospectively followed. Information on osteoporosis diagnosis, fractures, medications were collected annually by a detailed questionnaire. DXA examination of lumbar spine (L1-4) and hip were conducted at baseline and year five.

Results

Diagnosis and treatment in men with clinical fragility fractures was low: at baseline and year five only 2.3% and 10.3% of men with a clinical fracture reported an osteoporosis diagnosis, respectively. At year five, 90% of men with a clinical fragility fracture were untreated. Hip fractures were the most commonly treated (37.5% by year five). A diagnosis of osteoporosis resulted in greater treatment: 67% of participants with diagnosed osteoporosis were treated with a bisphosphonate and 87% were taking calcium and/or vitamin D (year five).

Conclusions

In this population-based study, both a diagnostic and therapeutic gap existed between knowledge and practice related to fragility fractures and osteoporosis in men aged ≥50 years.

National Osteoporosis Foundation (2002) America’s bone health: the state of osteoporosis and bone health. National Osteoporosis Foundation, Washington, DC. USA

Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2:285–289PubMedCrossRef

Pluijm SM, Tromp AM, Smit JH et al (2000) Consequences of vertebral deformities in older men and women. J Bone Miner Res 15:1564–1572PubMedCrossRef

Burger H, Van Daele PL, Grashuis K et al (1997) Vertebral deformities and functional impairment in men and women. J Bone Miner Res 12:152–157PubMedCrossRef

Jackson SA, Tenenhouse A, Robertson L (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11:680–687PubMedCrossRef

Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11:669–674PubMedCrossRef

Melton LJ 3rd, Chrischilles EA, Cooper C et al (2005) How many women have osteoporosis? JBMR Anniversary Classic. JBMR, Volume 7, Number 9, 1992. J Bone Miner Res 20:886–892PubMedCrossRef

Forsen L, Sogaard AJ, Meyer HE et al (1999) Survival after hip fracture: short- and long-term excess mortality according to age and gender. Osteoporos Int 10:73–78PubMedCrossRef

Jiang HX, Majumdar SR, Dick DA et al (2005) Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 20:494–500PubMedCrossRef

10.

Hawkes WG, Wehren L, Orwig D et al (2006) Gender differences in functioning after hip fracture. J Gerontol A Biol Sci Med Sci 61:495–499PubMed

11.

Osnes EK, Lofthus CM, Meyer HE et al (2004) Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int 15:567–574PubMedCrossRef

12.

Marottoli RA, Berkman LF, Leo-Summers L et al (1994) Predictors of mortality and institutionalization after hip fracture: the New Haven EPESE cohort. Established populations for epidemiologic studies of the elderly. Am J Public Health 84:1807–1812PubMed

13.

Papaioannou A, Wiktorowicz M, Adachi JD et al (2000) Mortality, independence in living, and re-fracture, one year following hip fractures in Canadians. J Obstet Gynaecol Can 22:591–597

14.

Elliot-Gibson V, Bogoch ER, Jamal SA et al (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef

15.

Papaioannou A, Giangregorio L, Kvern B et al (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 5:11PubMedCrossRef

16.

Giangregorio L, Papaioannou A, Cranney A et al (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305PubMedCrossRef

17.

National Osteoporosis Foundation [homepage on the Internet] Washington, DC. USA. National Osteoporosis Foundation, c2003 [cited June 2006]. Physician’s Guide to Prevention and Treatment of Osteoporosis; [about 1 screen]. Available from: http://noforg/physguide/

18.

(1996) Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada. CMAJ 155:1113–1133

19.

Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1–S34PubMed

20.

Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRef

21.

Klotzbuecher CM, Ross PD, Landsman PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef

22.

Phillipov G, Phillips PJ, Leach G et al (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556PubMedCrossRef

23.

Juby AG, Davis P (2001) A prospective evaluation of the awareness, knowledge, risk factors and current treatment of osteoporosis in a cohort of elderly subjects. Osteoporos Int 12:617–622PubMedCrossRef

24.

Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. CMAJ 163:819–822PubMed

25.

Kreiger N, Tenenhouse A, Joseph L et al (2002) The Canadian Multicenter Osteoporosis Study (CaMos): background, rationale, methods. Can J Aging 18:376–387

26.

Genant HK, Grampp S, Gluer CC et al (1994) Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503–1514PubMedCrossRef

27.

Tenenhouse A, Joseph L, Kreiger N et al (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904PubMedCrossRef

28.

Sawka AM, Thabane L, Papaioannou A et al (2005) A systematic review of the effect of alendronate on bone mineral density in men. J Clin Densitom 8:7–13PubMedCrossRef

29.

Ringe JD, Faber H, Farahmand P et al (2006) Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 26:427–431PubMedCrossRef

30.

Sawka AM, Papaioannou A, Adachi JD et al (2005) Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord 6:39PubMedCrossRef

31.

Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610PubMedCrossRef

32.

Simonelli C, Killeen K, Mehle S et al (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77:334–338PubMed

33.

Jaglal SB, McIsaac WJ, Hawker G et al (2003) Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int 14:672–676PubMedCrossRef

34.

Papaioannou A, Coker E, Kennedy CK et al (2004) A multi-faceted post fracture care model: the fracture? Think osteoporosis! Program. J Bone Miner Res 19:S318

35.

Bogoch ER, Elliot-Gibson V, Beaton DE et al (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88:25–34PubMedCrossRef

36.

Harrington JT, Barash HL, Day S et al (2005) Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project. Arthritis Rheum 53:198–204PubMedCrossRef

37.

Kmetic A, Joseph L, Berger C et al (2002) Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis. Epidemiology 13:437–444PubMedCrossRef

Title: The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study
Authors: A. Papaioannou
C. C. Kennedy
G. Ioannidis
Y. Gao
A. M. Sawka
D. Goltzman
A. Tenenhouse
L. Pickard
W. P. Olszynski
K. S. Davison
S. Kaiser
R. G. Josse
N. Kreiger
D. A. Hanley
J. C. Prior
J. P. Brown
T. Anastassiades
J. D. Adachi
CaMos Research Group
Publication date: 01-04-2008
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 4/2008
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-007-0483-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2008

Does thoracic or lumbar spine bone architecture predict vertebral failure strength more accurately than density?

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

Salmon calcitonin: a review of current and future therapeutic indications

Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)

Expressing fracture risk

Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application